| Thursday, October 6, 2022 - Friday, October 7, 2022 |
Associate Andy Antczak will moderate the closing plenary discussion at the Life Sciences Future – BioPharm 2022 conference in Philadelphia.
The discussion will focus on patent caretaking for gene therapy treatments for spinal muscular atrophy. Andy will be joined by leaders in the pharmaceutical industry who work tirelessly to find treatments and cures for patients around the globe.
The discussion, "Patient Spotlight: Gene Therapy Treatment for Spinal Muscular Atrophy," will take place on Thursday, October 6, 2022, from 3:00 PM-4:00 PM EST.